InsiderStreet Equity Research

Produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation for any investor. Do not rely on it for any investment decision.

Last Close

$302.30

2026-10-16

Market Cap

$79.9B

Volume

1.5M

52-Wk High

$311.34

52-Wk Low

$239.51

Trailing PE

12.5

P/S

0.28

Gross Margin

11.7%

Net Margin

2.3%

ROE

15%

ROIC

8%

Piotroski

8/9

Altman Z

2.8

1-Yr Return

+4.5%

5-Yr Return

+105.3%

Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.

SectorHealthcareIndustryMedical - Healthcare PlansExchangeNYSEMarket Cap$79.9BEmployees67,700 (SEC-filed)CEOBrian C. EvankoIPO1982-03-31CountryUS

900 Cottage Grove Road, Bloomfield, CT 06002 · Tel 860 226 6000 · thecignagroup.com

INSIDERSTREET SCORE61 / 100Street mean $344.86 (7 analysts, last qtr) — their number, not ours

INSIDER CONSENSUS SIGNALROUTINE SELLING — LOW SIGNAL$67M sold / 6 mo, zero open-market buys

1 Year vs S&P 500 · CI +4.5% · S&P 500 +15.9% · spread -11.4pp

7 Years vs S&P 500 · CI +105.3% · S&P 500 +189.9% · spread -84.6pp

Both charts indexed to 100 at the start of their window and drawn on a single shared scale, so the gap to the benchmark is the gap you see. Adjusted closes throughout.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

INSIDERSTREET
SCORE61of 100

Score Breakdown

Profitability	27/100
Growth	63/100
Momentum	90/100
Quality	70/100
Earnings Quality	84/100
Balance Sheet	48/100
Value	74/100
Risk (safety)	65/100
Overall	61.3/100

Each component is a diagnostic reading on its own 0-100 scale. The overall score is computed separately from the underlying financials and is not the average of the rows above — components are not equally weighted and three of them (Momentum, Value, Risk) are derived partly from price rather than from the business.

Peer Comparison — IS Score

Symbol	IS Score
ELV	57
CVS	52
HUM	27
CNC	37
UNH	51
MOH	30
CI	61

IS Score Trend — quarterly

14 quarters, 23 Q1 to 26 Q2. Peak 61 in 26 Q2, latest 61 — +0 since. Fell in 1 of the last 4 quarters. Dashed line marks 40 on the 0-100 scale.

BUSINESS QUALITY61 / 100IS Score 61.3 / 100 · +0.0 from peak of 61

Fundamental factor model, quarterly. Measures how the business is doing - not where the price is going.

PRICE STRUCTUREBULLISHTechnical Score 88 / 100 · Power +76 · 21 of 22 indicator votes bullish

Vote share across trend, momentum, volume, volatility and pattern families. Describes where the price is, not where it is going.

Both readings sit above the midpoint — business quality at 61 and price structure at 88 out of 100 — so they are not in conflict. The fundamentals and the tape are saying the same thing, which is the case in which either one alone would have been enough.

Trigger	Where it stands now	What it would mean
IS Score reaches 75 and holds two consecutive quarters	now 61.3	would move us up one band
IS Score stops falling - one quarter higher than the prior	last four: 61 → 58 → 60 → 61	the direction matters more than the level
Technical vote share back above 50%	now 91%	price structure no longer broken
Institutional holder count rises two quarters running	peak 1,731 → now 1,702	fewer institutions willing to hold is our clearest warning

We publish these so the view can be shown to be wrong. If none of them move and our reading does, we owe you an explanation.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

This page is InsiderStreet's own reading, produced from the data in the rest of this document. It is not a price target and not investment advice. Analyst consensus and street price targets appear later under their own heading and are the street's numbers, not ours.

Site Convergence Score3 of 4top 4% of 29,420 symbols

Sources Aligned— of 3independent disclosures

Congress (180d)3 buys2026-09-11

Insider Buys (180d)0none disclosed

ETF Funds (30d)1450 up / 1169 downnet +281 funds

Institutions Added (13F)41managers opening or increasing

Congressional and insider figures are disclosed purchases in the trailing 180 days; ETF figures are COUNTS OF FUNDS whose holding changed in 30 days, not dollars. Coincidence of separate disclosures, not coordination. An absent source means nothing qualifying was disclosed in its window.

Institutions holding — 12 quarters

Peak 1,731 · latest 1,702 (-29 from peak).

Quarter	Holders	13F shares	Value	Reported own%
2026 Q2	1,702	239.5M	$64.8B	90.7%
2026 Q1	1,661	235.1M	$61.4B	89.1%
2025 Q4	1,656	235.5M	$62.5B	89.2%
2025 Q3	1,615	233.3M	$62.5B	88.4%
2025 Q2	1,731	236.1M	$73.5B	89.4%
2025 Q1	1,691	241.0M	$74.0B	91.3%
2024 Q4	1,642	243.7M	$63.1B	92.3%
2024 Q3	1,700	242.5M	$79.2B	91.9%
2024 Q2	1,666	243.5M	$75.2B	92.2%
2024 Q1	1,662	250.9M	$84.9B	95.0%
2023 Q4	1,625	255.8M	$71.9B	96.9%
2023 Q3	1,491	256.0M	$68.8B	97.0%

How to read ownership above 100%. A 13F reports the positions a manager has investment discretion over, and where two or more managers share discretion over the same block, each one reports it. Summed across filers, the total can therefore exceed the shares actually outstanding without anything being wrong. We publish the figure as filed rather than netting it down, and flag separately any quarter where the arithmetic is not merely high but impossible.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Insider	Role	Date	Type	Shares	Value	Post-Txn Owned
Neville Everett	See Remarks	2026-09-03	SELL	617	$0.18M	5,053
Kurian George	director	2026-08-31	A-Award	109	—	2,042
Jones Nicole S	See Remarks	2026-08-18	SELL	2,677	$0.75M	25,880
Holgerson Bryan	See Remarks	2026-08-06	A-Award	1	—	945
Jones Nicole S	See Remarks	2026-08-05	EXERCISE	1,301	$0.25M	28,557
Jones Nicole S	See Remarks	2026-08-05	EXERCISE	1,301	$0.25M	0
Jones Nicole S	See Remarks	2026-08-04	EXERCISE	14,045	$2.70M	46,692
Jones Nicole S	See Remarks	2026-08-04	SELL	19,436	$5.37M	27,256

6-mo decomposition (Form 4)	Txns	Shares	Value	Signal weight
S — Open-market sales	19	229,533	$66.8M	Counted
M — Exercises (paired A/D)	7	228,788	$39.3M	None — mechanics
F — Tax withholding	13	25,098	$7.2M	None — compensation
P — Open-market purchases	0	0	$0	Counted — none occurred

Monthly Net Insider Flow (000 shares)

Net of acquisitions minus dispositions, all Form 4 types.

Signal Summary

SignalRoutine Selling — Low Signal

Open-Market Sells$66.8M19 txns / 6 mo

Open-Market Buys$0.0M0 txns / 6 mo

ClusterNone active3+ insiders / 21 days

Filed	Filer	Shares registered	Est. proceeds
2026-09-03	Neville Everett	617	$0.2M
2026-08-18	Jones Nicole S	2,677	$0.7M
2026-08-04	Jones Nicole S	19,436	$5.4M
2026-06-12	Kates Jamie G	899	$0.3M
Trailing 12 mo	9 filings	241,010	$70M

Filed	Form	Reporting person	% of class	Shares
2026-04-29	SCHEDULE 13G	Vanguard Capital Management	7.51%	19.8M sh
2026-03-26	SCHEDULE 13G/A	The Vanguard Group	—	exit/reporting change
2026-03-05	SCHEDULE 13G/A	The Vanguard Group	10.03%	26.4M sh
2025-11-05	SCHEDULE 13G/A	Abigail P. Johnson	4.00%	10.7M sh

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Member	Chamber	Trade	Size band	Traded	Disclosed
Ro Khanna	House	SELL	$1,001 - $15,000	2026-09-25	2026-10-09
Ro Khanna	House	BUY	$1,001 - $15,000	2026-09-11	2026-10-09
Ro Khanna	House	BUY	$1,001 - $15,000	2026-09-04	2026-10-09
Alan Armstrong	Senate	BUY	$1,001 - $15,000	2026-03-27	2026-07-21
Jerry Moran	Senate	SELL	$1,001 - $15,000	2023-12-14	2024-01-17
Jerry Moran	Senate	SELL	$1,001 - $15,000	2023-12-14	2024-01-17

House 12-Mo30 trades8 purchases

Senate 12-Mo1 trades1 purchases

CoverageSTOCK Act filings30-45 day disclosure lag

13F Filers (last complete Q)1,661

13F Shares235M89.1% of shares out

New / Closed156 / 118positions, QoQ

Increased / Reduced671 / 558positions, QoQ

Put/Call (13F)1.13option positions

Free Float99.5%263M sh

2.8 · Largest Reporting 13F Managers

Manager	Shares	Value
Assenagon Asset Management S.A.	314,127	$85M
Wealth Enhancement Advisory Servic	115,237	$30M
Fjarde Ap-Fonden /Fourth Swedish N	89,955	$24M
Asr Vermogensbeheer N.V.	82,000	$22M
Mn Services Vermogensbeheer B.V.	77,020	$21M
Czech National Bank	75,923	$21M

EDGAR 13F holdings as of 2026-09-30; filer values normalized to dollars.

2.9 · Top ETF & Fund Ownership

Fund	Weight	Position
VITSX	0.1%	$2.3B
VTSAX	0.1%	$2.3B
VSMPX	0.1%	$2.3B
VTI	0.1%	$2.3B
VFINX	0.1%	$1.9B
VOO	0.1%	$1.9B

13F Filers Holding CI — quarterly

Institutional Put/Call — quarterly

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Daily short-sale volume as % of volume reported in FINRA's short-sale file — a flow measure, not short interest; dashed = 50-day average.

Latest Session36.6%2026-10-15

20-Day Avg47.6%50-day 46.6%

TrendRising20d vs 50d

By Market CenterQ: 36% · N: 43% · B: 35%latest session

Weekly Notional ($B)

Where CI Trades in the Dark

ATS Venue (4-wk)	Shares	Avg trade
Incr Intelligent Cross Llc	1.9M	28 sh
Ubsa Ubs Ats	1.4M	30 sh
Ebxl Level Ats	1.0M	19 sh
Sgmt Sigma X2	1.0M	25 sh
Mlix Instinct X	0.8M	34 sh
Mstx Ms Trajectory Cross (Ats-1)	0.8M	20 sh

Where a dollar of Cigna Corporation revenue goes. All values FY2025 filings, live.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

CI (live moat model)Peer median: ELV · CVS · HUM · CNC · UNH

Component scores from the live moat model. Peer median illustrative.

Moat score 44/100 — Weak; primary source Efficient Scale.

3.8 · Employees (SEC filings)

Officer	Title
David Michael Cordani	Executive Chairman of the Board
Brian C. Evanko	President, CEO & Director
Nicole Susan Jones	Executive Vice President, Chief Administrative Officer & Chief Human Resources Officer
Ann Dennison	Executive Vice President & Chief Financial Officer

Revenue ($B)

EPS ($) — GAAP diluted actual, street-basis estimate

Actual bars are GAAP diluted EPS from the filed income statement; the lighter forward bars are street-basis consensus. The two are different measures and are not comparable quarter to quarter.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Quarterly EPS — Actual vs. Consensus

Beats (>2%)5 of 6recent quarters

Avg Surprise+2.8%

Next Report2026-11-05

Income Quality1.47OCF ÷ net income

Beat Rate—%0 of 0 quarters

Current Streak0longest 0

Avg EPS Surprise—%median —%

Surprise Trend—last 4 vs prior 4

Period	EPS est.	EPS actual	EPS surprise	Rev est. ($M)	Rev actual ($M)	Rev surprise

Announcement dates to . Consensus as it stood at each report. Revenue surprise shown where both estimate and actual are filed. A beat record is history, not a forecast.

Profit Margins (%)

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Revenue by Segment — Stacked

Live segmentation data.

YoY Growth Heatmap — Income Lines

YoY growth	FY21	FY22	FY23	FY24	FY25
Revenue	+8.5%	+3.7%	+8.2%	+26.6%	+11.3%
Gross profit	-5.2%	+2.4%	+7.1%	+3.1%	+0.1%
Operating income	-2.6%	+6.4%	+1.0%	+10.3%	-3.1%
Net income	-36.5%	+24.8%	-23.0%	-33.5%	+73.5%

$B · FY ends	FY21	FY22	FY23	FY24	FY25
Revenue	174.1	180.5	195.3	247.1	275.0
Cost of revenue	151.1	157.0	170.1	221.2	249.0
Gross profit	23.0	23.5	25.2	26.0	26.0
R&D expense	0.0	0.0	0.0	0.0	0.0
SG&A expense	12.8	13.0	14.3	14.6	14.0
Operating income	7.9	8.5	8.5	9.4	9.1
EBITDA	10.0	10.4	10.8	11.4	11.6
D&A	1.8	1.9	1.8	1.8	2.6
Pretax income	6.8	8.4	5.5	5.3	7.6
Income tax	1.4	1.6	0.1	1.5	1.3
Net income	5.4	6.7	5.2	3.4	6.0
Diluted EPS ($)	15.75	21.41	17.39	12.12	22.17
Diluted shares (M)	341	313	297	283	266

Operating CF$10B

CapEx$1B

Free cash flow$8B

SBC$0B

Buybacks$4B

Net cash change$0B

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Balance Sheet — Full

$B	FY22	FY23	FY24	FY25
Cash & equivalents	5.9	7.8	7.6	7.7
ST investments	0.9	0.9	0.7	0.0
Receivables (net)	17.0	17.5	24.1	28.8
Total current assets	30.1	37.4	48.9	47.8
PP&E (net)	1.3	0.9	0.8	3.7
Goodwill + intangibles	81.2	77.9	76.6	73.5
Total assets	143.9	152.8	155.9	157.9
Accounts payable	24.8	28.4	37.8	10.7
Short-term debt	3.0	2.7	3.0	0.6
Deferred revenue	0.0	0.0	0.0	0.0
Total current liabilities	41.2	48.7	58.0	56.3
Long-term debt	28.0	28.1	28.9	30.9
Total liabilities	99.0	106.4	114.6	116.0
Shareholders' equity	44.9	46.4	41.2	41.9

Cash Flow Statement — Full

$B	FY22	FY23	FY24	FY25
Net income	6.8	5.4	3.8	6.3
D&A	2.9	3.0	2.8	2.8
Stock-based compensation	0.0	0.0	0.0	0.0
Working capital change	0.6	3.5	1.2	0.2
Operating cash flow	8.7	11.8	10.4	9.6
Capital expenditures	(1.3)	(1.6)	(1.4)	(1.2)
Investing cash flow	3.1	(5.2)	(2.1)	(4.4)
Buybacks	(7.6)	(2.3)	(7.0)	(3.6)
Dividends paid	(1.4)	(1.5)	(1.6)	(1.6)
Debt issuance / (repay)	(2.6)	(0.3)	1.1	(0.7)
Financing cash flow	(11.2)	(4.3)	(7.6)	(6.4)
Free cash flow	7.4	10.2	9.0	8.4

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Balance Sheet Structure ($B)

Cash Generation vs Capex ($B)

Left: what the balance sheet is made of — the gap between the assets bar and the liabilities bar is book equity. Right: whether the capex bar is covered by the operating-cash bar; where it is not, the difference was funded externally and free cash flow goes negative.

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
PROFITABILITY
ROE	11.0%	14.6%	11.3%	7.9%	14.4%	15%
ROA	3.5%	4.5%	3.5%	2.2%	3.8%	4.1%
ROIC	8.4%	9.8%	12.2%	10.4%	11.5%	7.7%
Gross margin	13.2%	13.0%	12.9%	10.5%	9.5%	11.7%
Operating margin	4.6%	4.7%	4.4%	3.8%	3.3%	3.5%
Net margin	3.1%	3.7%	2.6%	1.4%	2.2%	2.3%
EBITDA margin	5.7%	5.8%	5.6%	4.6%	4.2%	4.5%
FCF margin	3.5%	4.1%	5.2%	3.6%	3.1%	—
VALUATION
P/E	13.14	14.29	16.47	21.89	12.29	12.5
P/B	1.50	2.13	1.84	1.83	1.75	1.9
P/S	0.40	0.53	0.44	0.30	0.27	0.28
P/FCF	11.68	13.01	8.30	8.39	8.73	8.8
EV/EBITDA	8.91	10.52	8.88	7.93	8.09	8.4
EV/Revenue	0.57	0.67	0.55	0.40	0.35	0.4
Earnings yield	7.6%	7.0%	6.1%	4.6%	8.1%	8.04%
FCF yield	8.6%	7.7%	12.0%	11.9%	11.5%	11.41%

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
LEVERAGE & SOLVENCY
Current ratio	0.83	0.73	0.77	0.84	0.85	0.85
Quick ratio	0.74	0.61	0.65	0.73	0.72	0.74
Debt / equity	0.73	0.70	0.67	0.78	0.75	0.75
Debt / assets	22.1%	21.9%	20.2%	20.5%	19.9%	20.3%
Net debt / EBITDA	2.55	2.16	1.84	1.90	1.99	2.04
Interest coverage	6.75	6.93	6.25	6.76	6.77	—

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
EFFICIENCY
Asset turnover	1.12	1.21	1.32	1.60	1.75	1.80
Receivables turnover	13.08	11.43	11.35	11.91	10.41	9.2
DSO (days)	28	32	32	31	35	40
DPO (days)	49	54	57	55	35	15
Cash conversion cycle	-13	-13	-14	-14	10	33
GROWTH (YoY)
Revenue growth	8.5%	3.7%	8.2%	26.6%	11.3%	—
Net income growth	-36.6%	25.0%	-23.0%	-33.5%	73.5%	—
EPS growth	-30.5%	34.9%	-20.1%	-29.5%	81.2%	—
FCF growth	-34.8%	21.9%	39.1%	-12.5%	-6.3%	—
PER SHARE ($)
EPS (diluted, TTM)	16.28	21.95	17.53	12.36	22.40	24.31
Book value / share	142.92	146.92	156.92	147.72	156.85	162.56
Revenue / share	528.08	591.06	662.89	889.62	1033.86	1069.78
FCF / share	18.31	24.10	34.76	32.24	31.54	34.52
Cash / share	18.20	22.36	29.69	29.57	28.86	23.86
SHAREHOLDER RETURN & SCORES
Buyback yield	11.0%	7.9%	2.7%	9.4%	4.9%	1.76%
Altman Z-Score	1.93	2.31	2.25	2.50	2.67	2.8
Piotroski F-Score	6	7	8	6	8	8/9
Beneish M-Score	-2.28	-2.41	-2.66	-2.20	-2.24	-2.82

Model	Score	Zone	Note
Piotroski F-Score	8 / 9	Strong
Altman Z-Score	2.8	Grey zone	Grey
Income quality	1.47	Cash-backed	OCF ÷ net income
Beneish M-Score	-2.82	Non-manipulator	vs −2.22 threshold

DuPont Decomposition (TTM)	Value
Tax burden	0.76
Interest burden	0.86
Operating margin	3.5%
Asset turnover	1.83×
Financial leverage	3.73×
= ROE	15%

Growth Quality (live)	Value
Revenue stability	0.93
Earnings stability	0.21
Earnings persistence	0.89
Revenue CAGR 3y	14.9%
EPS CAGR 3y	2.6%
FCF CAGR 3y	-7.2%

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Buyback Yield1.76%

Dividend Yield2.05%

Total Shareholder Return3.69%cash yield

SBC / Revenue0.0%dilution pressure

Company	Mkt cap	P/E	ROE	Net margin	Rev growth	Piotroski	1-yr ret
ELV	$92.9B	19.0	11%	2.9%	+6.3%	6/9	+23.6%
CVS	$118.1B	24.1	6%	2.8%	+7.4%	8/9	+14.4%
HUM	$49.6B	38.8	7%	1.7%	+18.3%	4/9	+54.6%
CNC	$34.2B	-6.7	-20%	2.5%	+8.7%	6/9	+94.0%
UNH	$360.3B	22.9	16%	3.6%	+3.3%	7/9	—
MOH	$10.8B	1296.0	-0%	0.6%	+2.6%	5/9	—
OSCR	$8.3B	18.6	34%	7.4%	+42.8%	7/9	—
REGN	$81.4B	18.9	14%	30.2%	+9.3%	7/9	—

1-yr returns computed from adjusted price history; peers without a tracked series show —.

Buy

39 Analysts

Str Sell (0)Sell (0)Hold (11)Buy (28)Str Buy (0)

Mean Target (qtr)$344.867 targets

Target vs. Price+14.1%last-quarter mean

Next Report2026-11-05street $7.52

Consensus estimates	Revenue mean	High / Low	EPS mean	High / Low	# EPS est.
FY2026	$287.16B	$289.75B / $281.03B	$30.51	$30.58 / $30.45	15
FY2027	$299.90B	$308.49B / $292.89B	$33.48	$33.86 / $33.13	15
FY2028	$316.02B	$323.83B / $305.86B	$37.14	$39.35 / $31.25	12

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Street Price Target — Trajectory

Window	Avg Target	vs. Price	# Targets
Last Month	$378.50	+25.2%	2
Last Quarter	$344.86	+14.1%	7
Last Year	$331.47	+9.6%	38
All Time	$329.97	+9.2%	89

Rolling mean of published targets vs. last close $302.30. Aggregated from StreetInsider, Benzinga, Pulse 2.0.

Third-Party Composite Rating

A-

DCF

5/5

ROE

4/5

ROA

4/5

Debt/Eq

1/5

P/E

3/5

P/B

4/5

Independent quant composite as of 2026-10-16; components scored 1–5 (5 best). Shown for contrast with the InsiderStreet Score — methodologies differ.

CI +4.5% vs S&P 500 +15.9% — spread -11.4pp

Sector — XLV +24.2%

Peer Set — indexed to 100

All series indexed to 100 at the start of the window, adjusted closes.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Candlesticks with SMA 20/50 overlay, Bollinger (20,2σ) band, volume, and Wilder RSI(14) — computed from live daily OHLCV.

Moving Average	Value	Distance	% Distance	Signal
SMA 20	$277.79	+24.51	+8.82%	Above
SMA 50	$278.61	+23.69	+8.50%	Above
SMA 200	$280.19	+22.11	+7.89%	Above
EMA 9	$288.13	+14.17	+4.92%	Above
EMA 21	$282.16	+20.14	+7.14%	Above
EMA 50	$280.39	+21.91	+7.81%	Above
EMA 200	$282.13	+20.17	+7.15%	Above

Series and readings from the nightly technical-indicator history — identical data to the site's ribbon chart. Supertrend segments colored by direction.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

TECHNICAL VERDICTBULLISHPower Score +7621 of 22 indicator votes bullish

Family Scores (site weights)

Trend 30%89

Momentum 25%100

Volume 20%94

Volatility 10%100

Patterns 15%50

This Week91% bullishof 11 price-based votes

4 Weeks Ago27%+64 pts since

12 Weeks Ago45%+46 pts since

ReadImprovingweek-over-week trajectory

Price vs SMA 20$277.79

Price vs SMA 50$278.61

Price vs SMA 200$280.19

EMA 9/21 Cross288.1/282.2

SMA 50/200Death

ADX DirectionADX 17

Supertrend$278

Parabolic SAR$275

SMA Slope1.360

RSI73.4

Stochastic K/D98/91

StochRSI K/D100/99

Williams %R-2

CCI212

TSI vs Signal19.0

CMO46.9

ROC11.82%

OBV SignalAccum

Chaikin MF0.210

MFI67

Force Index5M

Elder Ray Bull21.01

RSI (14)30 oversold · 70 overbought

Stochastic %Kvs %D 91

Money Flowvolume-weighted RSI

ADXtrend strength · <20 weak

Williams %Rinverted scale

Level	Value	Level	Value
Pivot / R1 / R2	$297.13 / $301.79 / $304.77	S1 / S2	$294.15 / $289.49
Bollinger (20,2)	$258.50 – $297.09	Squeeze	Off
52-wk range	$238.17 – $309.60	Off 52-wk high	-2.3%
ATR (14)	$7.43 (2.5%)	Historical vol	21.7%

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

+0.7%Jan55%

-0.5%Feb45%

+1.5%Mar52%

+0.0%Apr55%

+1.4%May55%

+1.0%Jun65%

-0.3%Jul55%

+4.3%Aug75%

-1.4%Sep40%

-0.8%Oct55%

+2.7%Nov80%

+3.2%Dec65%

Sample: 20 years — treat short histories as suggestive, not statistical.

Computed from live weekly prices	CI	S&P 500
Weekly volatility (σ, 1y)	4.39%	1.83%
Best / worst week (1y)	+8.5% / -19.0%	—
Max drawdown (5y, monthly)	-35.5%	—
1-week VaR (95%)	-6.8%	—
Beta (5y)	0.32	1.00

CI EQUITY WEATHER (LIVE)PARTLY CLOUDY · +30

Trend+44

Momentum+77

Volume+45

Volatility-60

Breadth-30

MARKET REGIME (2026-10-16)NEUTRAL

VIX19.99Normal

Dow TheoryConfirmed Bearish

SPY / QQQ TSI7.2 / 4.7trend strength

Sector Strength46/100breadth average

Average sentiment of 226 stories, weekly buckets, −1 to +1.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Overall+29.6+20.5 vs industry

Trend+44.5+5.5 vs industry

Momentum+77.3+21.3 vs industry

Volume+44.8+20.2 vs industry

Reading	CI	Medical - Healthcare Plans n=28	Healthcare n=5,272	All US symbols n=70,435
Overall	+29.6	+9.1	-24.0	-20.5
Trend	+44.5	+39.0	-25.6	-21.3
Momentum	+77.3	+56.0	-28.5	-15.8
Volume	+44.8	+24.6	-25.0	-3.8

Trend, momentum and volume are computed per company. Volatility and breadth are market-regime values shared by every symbol in the universe, so they are reported once under Market Regime rather than compared here - a company cannot differ from its sector on a constant.

Executive	Total comp	Structure
David M. Cordani Chair and Chief Executive O	$22.9M	75% equity+incentive
Brian C. Evanko President and Chief Operatin	$10.0M	72% equity+incentive
Nicole S. Jones Executive Vice President, Ch	$6.0M	68% equity+incentive
Ann M. Dennison Executive Vice President, Ch	$4.7M	72% equity+incentive
Everett Neville Executive Vice President, St	$4.1M	66% equity+incentive

Pillar (live disclosure scores)	Score
Environmental	66
Social	55
Governance	71
Composite ESG	64

Composite ESG Trend

Filed	8-K contents	Items
2026-10-09	Officer/Director Change	5.02
2026-09-30	Regulation FD; Exhibits	7.01,9.01
2026-07-30	Earnings Release; Exhibits	2.02,9.01
2026-05-13	Regulation FD	7.01
2026-04-30	Earnings Release; Exhibits	2.02,9.01
2026-04-27	Shareholder Vote	5.07
2026-03-03	Departure/Election of Directors; Appointment of Officers; Regulation F	5.02,7.01,9.01
2026-02-27	Regulation FD Disclosure	7.01

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Methodology. Every figure originates in InsiderStreet's production data layer and is computed deterministically by the same engines that power insiderstreet.ai. This factsheet contains no model-written text. Sections without underlying data are omitted rather than estimated.

DISCLOSURES. This document is produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation tailored to any person. Data is sourced as of the dates shown and may no longer be current. InsiderStreet.ai is not a registered investment adviser or broker-dealer. Investing involves risk, including loss of principal. Past performance does not guarantee future results. Do not make any investment decision based on this document. © 2026 InsiderStreet.ai — all rights reserved. Redistribution prohibited.

Data domain	Source	Coverage for this report
Price & volume	market_db.historical_prices	52 rows
Fundamentals	income_statements_annual	6 rows · 2020 to 2025
Reported vs consensus	fact/earnings_calendar	24 rows · 2020-11-05 to 2026-07-30
Analyst estimates	dim/forward_estimates	3 rows · 2026-12-31 to 2028-12-31
Institutional ownership (13F)	holdings_db.institutional_ownership_summary	51 rows · 2011 to 2026
Insider transactions (Form 4)	edgar/form4	12 rows · 2026-07-09 to 2026-09-03
Proposed sales (Form 144)	edgar/form144	1 record
Beneficial ownership (13D/G)	edgar/13dg	4 rows · 2025-11-05 to 2026-04-29
Short-sale volume (FINRA)	edgar/short_volume_daily	60 rows · 2026-07-23 to 2026-10-15
Dark pool (ATS, tier 1)	edgar/darkpool_weekly	12 rows · 2026-06-15 to 2026-08-31
ETF & fund holding	etf_holdings_changelog (30d)	1 record
Peer set	stock_peers_dynamic	8 rows
Industry medians	industry_medians	1 record
Congressional trades	congress_db (House + Senate)	1 record
ESG	fact/esg_disclosures	1 record

Method. Every figure in this factsheet is looked up from a named field computed in code. It contains no model-written text.

Not covered. Short interest as a percent of float and days-to-cover are not in this data set — the short-sale figures above are FINRA volume, a flow, and cannot support squeeze or covering analysis. Options positioning and intraday data are also absent. 13F ownership is filed 45 days after quarter end and congressional trades are disclosed on a lag, so both describe a past position, not a current one.

Cigna Corporation (CI)

Cigna Corporation (CI)

Score Breakdown

Peer Comparison — IS Score

IS Score Trend — quarterly

Cigna Corporation (CI)

Institutions holding — 12 quarters

Cigna Corporation (CI)

Monthly Net Insider Flow (000 shares)

Signal Summary

Cigna Corporation (CI)

2.8 · Largest Reporting 13F Managers

2.9 · Top ETF & Fund Ownership

13F Filers Holding CI — quarterly

Institutional Put/Call — quarterly

Cigna Corporation (CI)

Where CI Trades in the Dark

Cigna Corporation (CI)

3.8 · Employees (SEC filings)

Cigna Corporation (CI)

Cigna Corporation (CI)

Cigna Corporation (CI)

Balance Sheet — Full

Cash Flow Statement — Full

Cigna Corporation (CI)

Cigna Corporation (CI)

Cigna Corporation (CI)

Cigna Corporation (CI)

Street Price Target — Trajectory

Third-Party Composite Rating

Cigna Corporation (CI)

Cigna Corporation (CI)

Family Scores (site weights)

Cigna Corporation (CI)

Cigna Corporation (CI)

Cigna Corporation (CI)